Crispr Therapeutics shares owned by International Assets Investment Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by International Assets Investment Management
from 13F filings
Historical chart of International Assets Investment Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by International Assets Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by International Assets Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $827k | 39k | 21.29 |
| 2021-03-31 | $12k | 80 | 150.00 |
| 2020-12-31 | $12k | 80 | 150.00 |
More positions owned by International Assets Investment Management
View all positions for International Assets Investment Management